Bilateral retinal vein occlusion after two doses of SARS-CoV-2 adenovirus vector-based vaccine.

Fernández-Vigo, J I; Perálvarez Conde, C; Burgos-Blasco, B; Fernández-Vigo, J A

Fernández-Vigo, J I; Perálvarez Conde, C; Burgos-Blasco, B; Fernández-Vigo, J A.

Fernández-Vigo JI; Department of Ophthalmology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain; Centro Internacional de Oftalmología Avanzada, Madrid, Spain.
Perálvarez Conde C; Department of Ophthalmology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain.
Burgos-Blasco B; Department of Ophthalmology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Madrid, Spain. Electronic address: bburgos171@hotmail.com.
Fernández-Vigo JA; Centro Internacional de Oftalmología Avanzada, Madrid, Spain; Centro Internacional de Oftalmología Avanzada, Badajoz, Spain; Department of Ophthalmology, Universidad de Extremadura, Badajoz, Spain.

J Fr Ophtalmol ; 45(9): e397-e399, 2022 11.

Article in English | MEDLINE | ID: covidwho-1914596

Subject(s)

COVID-19; Retinal Vein Occlusion; Humans; COVID-19 Vaccines/adverse effects; Retinal Vein Occlusion/diagnosis; Retinal Vein Occlusion/etiology; SARS-CoV-2; COVID-19/prevention & control; Adenoviridae/genetics; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Retinal Vein Occlusion / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: J Fr Ophtalmol Year: 2022 Document Type: Article Affiliation country: J.jfo.2022.05.006

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google